Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Moodys
Farmers Insurance
Johnson and Johnson
Fuji

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for BGG492

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for BGG492

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
BGG492 ➤ Sign Up Fused bicylic pyridine compounds and their use as AMPA receptor modulators Janssen Pharmaceutica NV (Beerse, BE) ➤ Sign Up
BGG492 ➤ Sign Up 3-aryl-2H-pyrazolo[4,3-b]pyridine compounds and their use as AMPA receptor modulators Janssen Pharmaceutica NV (Beerse, BE) ➤ Sign Up
BGG492 ➤ Sign Up Fused azaheterocyclic compounds and their use as AMPA receptor modulators Janssen Pharmaceutica NV (Beerse, BE) ➤ Sign Up
BGG492 ➤ Sign Up Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands Novartis AG (Basel, CH) ➤ Sign Up
BGG492 ➤ Sign Up N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-q- uinazolin-3-yl)methanesulfonamide Novartis AG (Basel, CH) ➤ Sign Up
BGG492 ➤ Sign Up 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy Novartis AG (Basel, CH) ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for BGG492

Drugname Country Document Number Estimated Expiration Related US Patent
BGG492 Australia 2017350689 2036-10-26 ➤ Sign Up
BGG492 Canada 3039676 2036-10-26 ➤ Sign Up
BGG492 World Intellectual Property Organization (WIPO) 2018080917 2036-10-26 ➤ Sign Up
BGG492 World Intellectual Property Organization (WIPO) 2018080918 2036-10-26 ➤ Sign Up
BGG492 Australia 2017350688 2036-10-26 ➤ Sign Up
BGG492 Canada 3039208 2036-10-26 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
McKesson
Medtronic
Federal Trade Commission
Baxter
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.